Vemircopan

Cat. No. M11511

All AbMole products are for research use only, cannot be used for human consumption.

Synonym:

ALXN2050; ACH 0145228; ACH-5228

For this product's availability, delivery time and price, please email [email protected] directly or click the "Inquiry Now" button below.

Vemircopan (ALXN2050) is an oral active complement factor D (FD) inhibitor.

Related Complement System Products
JPE-1375 JPE-1375 is a complement C5a receptor 1 (C5aR1) antagonist. JPE-1375 effectively inhibits polymorphonuclear leukocyte mobilization (EC50=6.9 µM) and reduces TNF levels (EC50=4.5 µM) in mice.
C5aR-IN-1 C5aR-IN-1 is a potent inhibitor of C5aR.
EG01377 dihydrochloride EG01377 dihydrochloride is a potent, bioavailable and selective inhibitor of neuropilin-1 (NRP1), with a Kd of 1.32 μM, and IC50s of 609 nM for both NRP1-a1 and NRP1-b1.
Empasiprubart Empasiprubar (ARGX-117) is a humanized inhibitory monoclonal antibody targeting complement C2. Empasiprubar binds to the Sushi-2 domain of C2, preventing the formation of C3 pre convertase and inhibiting the activation of classical and lectin pathways upstream of C3 activation.
Avacincaptad pegol sodium Avacincaptad pegol (ARC1905) is an anti-C5 RNA aptamer that inhibits the cleavage of complement factor 5 (C5) into C5a and C5b.

Catalog